Some parts of the portal may cause error messages or display incorrectly due to the transition to a new provider of trading data

TMDX - TransMedics Group, Inc.

IEX Last Trade
62.58
0.260   0.415%

Share volume: 19,428
Last Updated: Thu 26 Dec 2024 08:30:03 PM CET
Surgical and Medical Instrument Manufacturing : 1.09%

PREVIOUS CLOSE
CHG
CHG%
$62.32
0.26
0.42%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Overview Charts Financials Fundamental analysis Historical prices Events Documents Notes Dividends
Fundamental analysis
35%
Profitability 17%
Dept financing 42%
Liquidity 75%
Performance 41%
Company vs Stock growth
vs
+ Add row to compare
Performance
5 Days
2.00%
1 Month
-20.73%
3 Months
-55.80%
6 Months
-55.83%
1 Year
-20.81%
2 Year
7.41%
Key data
Stock price
$62.58
P/E Ratio 
1,868.79
DAY RANGE
$61.50 - $63.28
EPS 
$0.09
52 WEEK RANGE
$62.40 - $177.37
52 WEEK CHANGE
-$21.19
MARKET CAP 
5.606 B
YIELD 
N/A
SHARES OUTSTANDING 
33.359 M
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
11/04/2024
BETA 
1.57
PUBLIC FLOAT 
$0
AVERAGE 10 VOLUME 
$1,296,517
AVERAGE 30 VOLUME 
$1,727,292
Company detail
CEO: Waleed H. Hassanein
Region: US
Website: transmedics.com
Employees: 210
IPO year: -
Issue type: Common Stock
Market: XNAS
Industry: Surgical and Medical Instrument Manufacturing
Sector: Manufacturing

TransMedics Group, Inc. engages in transforming organ transplant therapy for end-stage organ failure patients in the United States and internationally. The company offers Organ Care System (OCS), a portable organ perfusion, optimization, and monitoring system. OCS LUNG for the preservation of standard criteria donor lungs for double-lung transplantation.

Recent news